When tested in the in vitro T-cell proliferation assay, H-2a cells are nonresponders to lactate dehydrogenase B (LDH-B; L-lactate:NAD+ oxidoreductase, EC 1.1.1.27) and to IgG2a myeloma protein. However, the cells can be converted into responders either by the addition to the culture of monoclonal anti-Ia.m7 antibody or by the removal from the culture of Lyt-2+ [T-lymphocyte-associated alloantigen (Lyt)-2 positive] lymphocytes. In both instances, the responsiveness can be suppressed again by the addition to the culture of monoclonal antibodies to I region-associated (Ia) molecules controlled by the I-A subregion. These data suggest that, in some H-2 haplotypes, the response to LDH-B and IgG2a is the result of interaction between the I-A and I-E subregions. The H-2a haplotype carries a responder allele at the I-A subregion but the responsiveness of H-2a cells is normally suppressed by T cells recognizing the antigen in the context of the I-E molecules. When the recognition of I-E molecules is blocked by an antiserum or when the cells capable of this recognition are removed, the H-2a cells become responders. These experiments demonstrate a nonresponder turned responder by antibody inhibition. They also demonstrate that the postulate of the I-B subregion is no longer necessary and provide additional evidence that the Ia molecules are the products of the immune response (Ir) genes.
No takes yet. Share an insight, caveat, or question.
Baxevanis et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: